Open-label, randomized, multi-center study investigating Cetuximab, in combination with concurrent chemo- / radiotherapy in locally advanced non-small cell lung carcinoma.

Trial Profile

Open-label, randomized, multi-center study investigating Cetuximab, in combination with concurrent chemo- / radiotherapy in locally advanced non-small cell lung carcinoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Sep 2015

At a glance

  • Drugs Cetuximab (Primary) ; Cisplatin
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RADITUX
  • Most Recent Events

    • 09 Sep 2015 Results of 60 months follow up presented at the 16th World Conference on Lung Cancer
    • 05 Jun 2012 Efficacy outcomes presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
    • 15 Mar 2012 Planned number of patients changed from 110 to 112 as reported by EudraCT.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top